The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
Official Title: A Multicenter, Randomized Double-Blind Phase II/III Study in the First-Line Treatment of Advanced Transitional Cell Carcinoma (TCC) of the Urothelium Comparing Vinflunine/Gemcitabine to Placebo/Gemcitabine in Patients Who Are Ineligible to Receive Cisplatin-Based Therapy
Study ID: NCT00389155
Brief Summary: The purpose of this study is to test an investigational drug, vinflunine (BMS-710485), in combination with gemcitabine in patients with Transitional Cell Carcinoma who cannot be treated with cisplatin. This study will help to determine whether vinflunine in combination with gemcitabine will extend the time period until further growth of the tumor more than gemcitabine alone.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University Of Alabama At Birmingham, Birmingham, Alabama, United States
Acrc/Arizona Clinical Research Center, Inc., Tucson, Arizona, United States
Tower Hematology Oncology Medical Group, Beverly Hills, California, United States
Local Institution, Concord, California, United States
Glendale Memorial Hospital And Health Center, Glendale, California, United States
Moores Ucsd Cancer Center, La Jolla, California, United States
North Valley Hematology/Oncology Medical Group, Mission Hills, California, United States
Local Institution, Orange, California, United States
Stanford University, Stanford, California, United States
Local Institution, Newark, Delaware, United States
University Of Florida College Of Medicine At Jacksonville, Jacksonville, Florida, United States
Local Institution, Jacksonville, Florida, United States
Lakeland Regional Cancer Center, Lakeland, Florida, United States
University Of Miami, Miami, Florida, United States
Advanced Medical Specialties, Miami, Florida, United States
Medical College Of Georgia, Augusta, Georgia, United States
Central Georgia Cancer Care, Pc, Macon, Georgia, United States
University Of Chicago, Chicago, Illinois, United States
Springfield Clinic, Llp, Springfield, Illinois, United States
Michiana Hematology Oncology, P.C., South Bend, Indiana, United States
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore, Maryland, United States
Henry Ford Hospital, Detroit, Michigan, United States
Mitchell Folbe, Md, Pc, Troy, Michigan, United States
Local Institution, Minneapolis, Minnesota, United States
Local Institution, Rochester, Minnesota, United States
Missouri Cancer Associates, Columbia, Missouri, United States
University Of Missouri Healthcare/Ellis Fischel Cancer Ctr, Columbia, Missouri, United States
Capital Comprehensive Cancer Care Center, Jefferson City, Missouri, United States
Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, United States
Washington University School Of Medicine, St. Louis, Missouri, United States
Billings Clinic, Billings, Montana, United States
Hematology Oncology Centers Of The Northern Rockies, Pc, Billings, Montana, United States
Nevada Cancer Institute, Las Vegas, Nevada, United States
Nevada Cancer Centers, Las Vegas, Nevada, United States
The Cancer Center At Hackensack University Medical Center, Hackensack, New Jersey, United States
Albert Einstein Cancer Center, Bronx, New York, United States
The Mary Imogene Bassett Hospital, Cooperstown, New York, United States
Columbia University Medical Center, New York, New York, United States
New York Presbyterian Hospital, New York, New York, United States
University Of Rochester, Rochester, New York, United States
Carolinas Hematology Oncology Associates, Charlotte, North Carolina, United States
Mid Dakota Clinic, Pc, Bismarck, North Dakota, United States
Cleveland Clinic, Cleveland, Ohio, United States
Mid-Ohio Oncology/Hematology, Inc. Dba, Columbus, Ohio, United States
Abramson Cancer Center Of The, Philadelphia, Pennsylvania, United States
Guthrie Foundation For Education And Research, Sayre, Pennsylvania, United States
Charleston Cancer Center, Charleston, South Carolina, United States
Medical University Of South Carolina, Charleston, South Carolina, United States
The Jones Clinic, Pc, Germantown, Tennessee, United States
The West Clinic, Memphis, Tennessee, United States
The Sarah Cannon Research Institute, Nashville, Tennessee, United States
Lone Star Oncology Consulants, Pa, Austin, Texas, United States
Cancer Specialists Of South Texas, Pa, Corpus Christi, Texas, United States
The Center For Cancer And Blood Disorders, Fort Worth, Texas, United States
University Of Texas Medical Branch Of Galveston, Galveston, Texas, United States
South Texas Oncology And Hematology, P.A., San Antonio, Texas, United States
Northern Utah Associates, Ogden, Utah, United States
Cancer Outreach Associates, Pc, Abingdon, Virginia, United States
Virginia Oncology Associates, Norfolk, Virginia, United States
Virginia Mason Medical Center, Seattle, Washington, United States
Univ. Of Washington Medical Ctr., Prostate-Oncology Ctr, Seattle, Washington, United States
West Virginia University, Morgantown, West Virginia, United States
Local Institution, Milwaukee, Wisconsin, United States
Local Institution, Tweed Heads, New South Wales, Australia
Local Institution, Adelaide, South Australia, Australia
Local Institution, Antwerp, , Belgium
Local Institution, Edegem, , Belgium
Local Institution, Moncton, New Brunswick, Canada
Local Institution, Sydney, Nova Scotia, Canada
Local Institution, London, Ontario, Canada
Local Institution, Montreal, Quebec, Canada
Local Institution, Arhus, , Denmark
Local Institution, Herlev, , Denmark
Local Institution, Kobenhavn O, , Denmark
Local Institution, Odense C, , Denmark
Local Institution, Caen Cedex 05, , France
Local Institution, Paris Cedex 14, , France
Local Institution, Vandoeuvre Les Nancy, , France
Local Institution, Athens, , Greece
Local Institution, Jakarta, , Indonesia
Local Institution, Milan, , Italy
Local Institution, Trento, , Italy
Local Institution, Viterbo, , Italy
Local Institution, Seongnam, Gyeonggi-Do, Korea, Republic of
Local Institution, Seoul, , Korea, Republic of
Local Institution, Seoul, , Korea, Republic of
Local Institution, Cebu, , Philippines
Local Institution, Davao City, , Philippines
Local Institution, Manila, , Philippines
Local Institution, Quezon City, , Philippines
Local Institution, Bialystok, , Poland
Local Institution, Cracow, , Poland
Local Institution, Gdansk, , Poland
Local Institution, Olsztyn, , Poland
Local Institution, Poznan, , Poland
Local Institution, Warsaw, , Poland
Local Institution, Obninsk, Kaluga Region, Russian Federation
Local Institution, Moscow, , Russian Federation
Local Institution, Saint Petersburg, , Russian Federation
Local Institution, St Petersburg, , Russian Federation
Local Institution, Barcelona, , Spain
Local Institution, Barcelona, , Spain
Local Institution, Murcia, , Spain
Local Institution, Palma De Mallorca, , Spain
Local Institution, Sabadell (Barcelona), , Spain
Local Institution, Santander, , Spain
Local Institution, Bangkok, , Thailand
Local Institution, Cardiff, Glamorgan, United Kingdom
Local Institution, Grimsby, Lincolnshire, United Kingdom
Local Institution, Nottingham, Nottinghamshire, United Kingdom
Local Institution, Birmingham, West Midlands, United Kingdom
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR